Order Article Reprints

Ikeda M, Koh Y, Teraoka S, Sato K, Oyanagi J, Hayata A, Tokudome N, Akamatsu H, Ozawa Y, Endo K, et al. Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab. Cancers. 2021; 13(10):2290. https://doi.org/10.3390/cancers13102290

Ikeda, Mio, Yasuhiro Koh, Shunsuke Teraoka, Koichi Sato, Jun Oyanagi, Atsushi Hayata, Nahomi Tokudome, Hiroaki Akamatsu, Yuichi Ozawa, Katsuya Endo, and et al. 2021. "Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab" Cancers 13, no. 10: 2290. https://doi.org/10.3390/cancers13102290

Ikeda, M., Koh, Y., Teraoka, S., Sato, K., Oyanagi, J., Hayata, A., Tokudome, N., Akamatsu, H., Ozawa, Y., Endo, K., Higuchi, M., Nakanishi, M., Ueda, H., & Yamamoto, N. (2021). Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab. Cancers, 13(10), 2290. https://doi.org/10.3390/cancers13102290